Esmolol in Cardiac Surgery: A Randomized Controlled Trial
In the present trial, esmolol as a cardioplegia adjuvant enhanced postoperative cardiac performance but did not reduce a composite endpoint of prolonged intensive care unit stay and/or mortality.
Del Nido Microplegia Compared to Standard 1:4 Crystalloid Del Nido for Myocardial Protection
Editor’s Note: We had a fun discussion with a couple of our surgeons today regarding the use of Del Nido cardioplegia. At this institution we have been deploying the microplegia version of Del Nido, and subsequently substituting Blood as the crystalloid component, delivering the primary dose in 1,200 ml aliquots, and then redosing at 60…